There is a pressing need to better understand this type of cancer at the genomic level from the early premalignant stage through to tumor progression and metastasis stage in order to develop effective strategies for the prevention and treatment of BRCA1-associated breast cancer. This evidence concerns the gene BRCA1 and breast cancer.